Showing results (341-350 of 420) with videos related to

Sort By:
Pageof 42
Genome Biology|April 16, 2021
Subtype-associated epigenomic landscape and 3D genome structure in bladder cancerTejaswi Iyyanki, Baozhen Zhang, Qixuan Wang, et al.
Journal of Surgical Education|January 23, 2025
Impact of Subsequent Fellowship on Urology Chief Resident Case Log VolumesRaidizon Mercedes, Zachary Corey, Talmadge Gaither, et al.
The Journal of Urology|December 30, 2022
Urinary Analysis of FGFR3 and TERT Gene Mutations Enhances Performance of Cxbladder Tests and Improves Patient Risk StratificationYair Lotan, Jay D Raman, Badrinath Konety, et al.
Urology Practice|August 28, 2024
Practice Readiness? Trends in Chief Resident Case Logs vs Subsequent Case Log Data in Clinical PracticeZachary Corey, Erik Lehman, Gary E Lemack, et al.
The Journal of Urology|July 24, 2020
Microhematuria: AUA/SUFU GuidelineDaniel A Barocas, Stephen A Boorjian, Ronald D Alvarez, et al.
The Journal of Urology|July 21, 2009
Adjuvant chemotherapy for high risk upper tract urothelial carcinoma: results from the Upper Tract Urothelial Carcinoma CollaborationNicholas J Hellenthal, Shahrokh F Shariat, Vitaly Margulis, et al.
Oncogene|October 23, 2019
Hypermethylation of FOXA1 and allelic loss of PTEN drive squamous differentiation and promote heterogeneity in bladder cancerVasty Osei-Amponsa, Jenna M Buckwalter, Lauren Shuman, et al.
World Journal of Urology|June 9, 2016
HER2 overexpression is associated with worse outcomes in patients with upper tract urothelial carcinoma (UTUC)Francesco Soria, Marco Moschini, Andrea Haitel, et al.
BJU International|November 8, 2008
Risk stratification of patients with nodal involvement in upper tract urothelial carcinoma: value of lymph-node densityChristian Bolenz, Shahrokh F Shariat, Mario I Fernández, et al.
Pageof 42